Published in Cancer Med on September 26, 2016
Patient-derived xenografts as in vivo models for research in urological malignancies. Nat Rev Urol (2017) 0.75
Potential Role of Chemokines in Fracture Repair. Front Endocrinol (Lausanne) (2017) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods (1994) 13.53
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
Distinct role of macrophages in different tumor microenvironments. Cancer Res (2006) 9.29
Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 7.83
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A (1996) 5.69
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60
Role of VHL gene mutation in human cancer. J Clin Oncol (2004) 5.46
Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol (1995) 4.37
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34
Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res (2010) 4.15
Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell (2013) 3.75
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer (2006) 3.05
Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res (2005) 3.00
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res (2007) 2.77
Metastatic renal cell carcinoma. Curr Treat Options Oncol (2003) 2.50
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma. Sci Transl Med (2012) 1.84
Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem (2009) 1.81
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma. Urol Oncol (2008) 1.63
Checkpoint blocking antibodies in cancer immunotherapy. FEBS Lett (2013) 1.54
Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci (2013) 1.50
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol (2014) 1.47
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci (2011) 1.46
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol (2006) 1.44
Renal cancer: molecular mechanisms and newer therapeutic options. Curr Opin Nephrol Hypertens (2002) 1.38
Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res (2011) 1.34
Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. Am J Pathol (2006) 1.16
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep (2015) 1.14
Chemokines in tumor development and progression. Exp Cell Res (2011) 1.08
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother (2013) 1.08
Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol (2003) 1.07
JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma. Oncogene (2011) 0.94
CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer. Clin Cancer Res (2015) 0.88
New agents in renal cell carcinoma. Target Oncol (2013) 0.86
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma. PLoS One (2015) 0.82
Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy. Cancer Sci (2012) 0.80
Determining the efficacy of ultrasonography for the detection of ureteral stone. Urology (2014) 1.43
Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era. Int J Urol (2015) 1.40
A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population. J Med Genet (2014) 0.83
Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy. Cancer Sci (2012) 0.80
Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases. Pathol Int (2015) 0.78
Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer. Cancer Biomark (2015) 0.77
Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer. Clin Genitourin Cancer (2015) 0.76
Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Cancer Sci (2017) 0.75
An original patient-derived xenograft of prostate cancer with cyst formation. Prostate (2016) 0.75
Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation. Transpl Infect Dis (2017) 0.75
Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma. Methods Mol Biol (2018) 0.75
Three-dimensional simulation analysis of microdissection testicular sperm extraction for patients with non-obstructive azoospermia. Andrology (2020) 0.75
Asian School of Urology, Young Leaders' Workshop, Kyoto 2010. Int J Urol (2010) 0.75
Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients with Nocturnal Polyuria. Urology (2017) 0.75
Bowel perforation by a peritoneal dialysis catheter: report of two cases. BMC Nephrol (2017) 0.75
Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study. Clin Genitourin Cancer (2017) 0.75
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. Urol Oncol (2021) 0.75
Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration. Int J Urol (2017) 0.75